Status:
UNKNOWN
Myocardial Perfusion Assessment With Multidetector Computed Tomography
Lead Sponsor:
Tennessee Heart and Vascular Institute, P.C.
Collaborating Sponsors:
General Electric
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
Demonstrate the ability of muti-detector computed tomography to adequately perform stress testing will result in a veritable "one-stop shop" of non-invasive cardiac imaging that is, the ability to dir...
Eligibility Criteria
Inclusion
- Adults \>18 years of age
- Adults undergoing myocardial perfusion SPECT imaging
- Adults with suspected coronary artery disease
Exclusion
- Age \<18
- Known or suspected renal insufficiency (Creatinine \<1.7 mg/dl)
- Allergy to contrast
- Inability or contraindication to lexiscan or beta blocker
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00846079
Start Date
February 1 2009
End Date
September 1 2009
Last Update
February 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tennessee Heart and Vascular Institute
Hendersonville, Tennessee, United States